Evolus Statistics
Want to see EOLS full AI Analyst Report?
Evolus (EOLS) Stock Statistics & Valuation Metrics
Total Valuation
Evolus has a market cap or net worth of $450.41M. The enterprise value is $652.57M.
- Market Cap
- $450.41M
- Enterprise Value
- $652.57M
Share Statistics
Evolus has 66,188,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 66,188,370
- Owned by Insiders
- 2.82%
- Owned by Institutions
- 22.92%
Financial Efficiency
Evolus’s return on equity (ROE) is 2.23 and return on invested capital (ROIC) is -24.56%.
- Return on Equity (ROE)
- 2.23
- Return on Assets (ROA)
- -0.23
- Return on Invested Capital (ROIC)
- -24.56%
- Return on Capital Employed (ROCE)
- -0.25
- Revenue Per Employee
- 841.86K
- Profits Per Employee
- -146.29K
- Employee Count
- 353
- Asset Turnover
- 1.32
- Inventory Turnover
- 3.87
Valuation Ratios
The current PE Ratio of Evolus is -14.91. Evolus’s PEG ratio is -0.20.
- PE Ratio
- -14.91
- PS Ratio
- 1.42
- PB Ratio
- -12.20
- Price to FCF
- -62.97
- Price to Operating Cash Flow
- -174.40
- PEG Ratio
- -0.20
Income Statement
In the last 12 months, Evolus had revenue of 297.18M and earned -51.64M in profits. Earnings per share was -0.80.
- Revenue
- 297.18M
- Gross Profit
- 192.76M
- Operating Income
- -37.60M
- Pretax Income
- -50.96M
- Net Income
- -51.64M
- EBITDA
- -22.53M
- Earnings Per Share (EPS)
- -0.80
Cash Flow
In the last 12 months, operating cash flow was -2.65M and capital expenditures -4.68M, giving a free cash flow of -7.32M billion.
- Operating Cash Flow
- -2.65M
- Free Cash Flow
- -7.32M
- Free Cash Flow per Share
- -0.11
Dividends & Yields
Evolus pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.21%
- Earnings Yield
- -6.75%
Stock Price Statistics
- Beta
- 1.02
- 52-Week Price Change
- -5.22%
- 50-Day Moving Average
- 7.82
- 200-Day Moving Average
- 6.34
- Relative Strength Index (RSI)
- 38.61
- Average Volume (3m)
- 868.53K
Important Dates
Evolus upcoming earnings date is Mar 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 09, 2027
- Ex-Dividend Date
- ―
Financial Position
Evolus as a current ratio of 1.90, with Debt / Equity ratio of -670.80%
- Current Ratio
- 1.90
- Quick Ratio
- 1.54
- Debt to Market Cap
- 0.34
- Net Debt to EBITDA
- -4.49
- Interest Coverage Ratio
- -1.91
Taxes
In the past 12 months, Evolus has paid 677.00K in taxes.
- Income Tax
- 677.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Evolus EV to EBITDA ratio is -132.17, with an EV/FCF ratio of -104.47.
- EV to Sales
- 1.80
- EV to EBITDA
- -132.17
- EV to Free Cash Flow
- -104.47
- EV to Operating Cash Flow
- -221.02
Balance Sheet
Evolus has $41.70M in cash and marketable securities with $165.59M in debt, giving a net cash position of -$123.89M billion.
- Cash & Marketable Securities
- $41.70M
- Total Debt
- $165.59M
- Net Cash
- -$123.89M
- Net Cash Per Share
- -$1.87
- Tangible Book Value Per Share
- -$1.60
Margins
Gross margin is 65.91%, with operating margin of -5.69%, and net profit margin of -9.56%.
- Gross Margin
- 65.91%
- Operating Margin
- -5.69%
- Pretax Margin
- -9.32%
- Net Profit Margin
- -9.56%
- EBITDA Margin
- -1.36%
- EBIT Margin
- -4.29%
Analyst Forecast
The average price target for Evolus is $16.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $16.25
- Price Target Upside
- 138.80% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 13.87%
- EPS Growth Forecast
- 48.13%
Scores
- Smart Score
- 8
- AI Score
- 48
